{"nct_id":"NCT01345253","title":"GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2011-05-23","start_date_type":"ACTUAL","primary_completion_date":"2015-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}